Chordia Therapeutics,Inc
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
190A | T
Overview
Corporate Details
- ISIN(s):
- JP3283730004
- LEI:
- Country:
- Japan
- Address:
- 藤沢市村岡東２−２６−１
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Chordia Therapeutics Inc. is a clinical-stage biotechnology company specializing in the research and development of innovative, first-in-class anti-cancer drugs. Established in November 2017 as a spin-out from a major pharmaceutical company, its mission is to deliver novel treatments to patients with unmet medical needs. The company focuses on developing a pipeline of small-molecule drug candidates that target RNA deregulation stress, a key factor in cancer development. Chordia Therapeutics operates with a focused R&D model, outsourcing activities such as manufacturing, distribution, and sales to external partners to advance its therapeutic programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-05 08:30 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 534.8 KB | ||
| 2025-05-16 02:45 |
Regulatory News Service
臨時報告書
|
Japanese | 20.2 KB | ||
| 2025-04-11 04:50 |
Interim Report
半期報告書－第8期(2024/09/01－2025/08/31)
|
Japanese | 144.4 KB | ||
| 2025-04-11 04:50 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2024-12-17 07:30 |
Registration Form
訂正確認書
|
Japanese | 8.7 KB | ||
| 2024-11-29 07:37 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.1 KB | ||
| 2024-11-29 07:36 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2024-11-29 07:35 |
Governance Information
内部統制報告書－第7期(2023/09/01－2024/08/31)
|
Japanese | 21.2 KB | ||
| 2024-11-29 07:34 |
Annual Report
有価証券報告書－第7期(2023/09/01－2024/08/31)
|
Japanese | 2.8 MB | ||
| 2024-07-16 06:55 |
Quarterly Report
四半期報告書－第7期第3四半期(2024/03/01－2024/05/31)
|
Japanese | 123.4 KB | ||
| 2024-07-16 06:55 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2024-06-06 08:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.9 MB | ||
| 2024-05-29 04:00 |
Regulatory News Service
訂正有価証券届出書（新規公開時）
|
Japanese | 2.9 MB | ||
| 2024-05-10 08:00 |
Prospectus
有価証券届出書（新規公開時）
|
Japanese | 5.7 MB |
Automate Your Workflow. Get a real-time feed of all Chordia Therapeutics,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chordia Therapeutics,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chordia Therapeutics,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
